Anti-inflammatory interleukin-10 genotype protects dialysis patients from cardiovascular events

Kidney International

Volumn 62, Issue 3, 2002, Pages 949-955

  Girndt, Matthias ^a   Kaul, Harald ^a   Sester, Urban ^a   Ulrich, Christof ^a   Sester, Martina ^a   Georg, Thomas ^a   Köhler, Hans ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Arteriosclerosis; C reactive protein; Chronic renal failure; Hemodialysis; Progressive renal disease; Uremia

Indexed keywords

ANTIINFLAMMATORY AGENT; BIOLOGICAL MARKER; C REACTIVE PROTEIN; INTERLEUKIN 10;

ADULT; AGED; ALLELE; ARTERY DISEASE; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; CELL PROTECTION; CEREBROVASCULAR DISEASE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIALYSIS; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HEART DISEASE; HEMODIALYSIS; HUMAN; INFLAMMATION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRIORITY JOURNAL; PROMOTER REGION; PROSPECTIVE STUDY; RISK FACTOR;

EID: 0036422425     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2002.00504.x     Document Type: Article

References (21)

1. Ridker PM, Cushman M, Stampfer MJ, et al: Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336:973-979, 1997
2. Ross R: Atherosclerosis - An inflammatory disease. N Engl J Med 340:115-126, 1999
3. Lindahl B, Toss H, Siegbahn A, et al: Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. N Engl J Med 343:1139-1147, 2000
4. Mehta JL, Saldeen T, Rand K: Interactive role of infection, inflammation and traditional risk factors in atherosclerosis and coronary artery disease. J Am Coll Cardiol 31:1217-1225, 1998
5. US Renal Data System: USRDS 1998 Annual Data Report. Am J Kidney Dis 32(Suppl):S9-S162, 1998
6. Girndt M, Sester U, Kaul H, Köhler H: Production of pro-inflammatory and regulatory monokines in hemodialysis patients shown at a single cell level. J Am Soc Nephrol 9:1689-1696, 1998
7. Zimmermann J, Herrlinger S, Pruy A, et al: Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 55:648-658, 1999
8. Moore KW, O'Garra A, De Waal Malefyt R, et al: Interleukin-10. Annu Rev Immunol 11:165-190, 1993
9. Turner DM, Williams DM, Sankaran D, et al: An investigation of polymorphism in the interleukin-10 gene promotor. Eur J Immunogen 24:1-8, 1997
10. Perrey C, Turner SJ, Pravica V, et al: ARMS-PCR methodologies to determine IL-10, TNF-alpha, TNF-beta and TGF-beta 1 gene polymorphisms. Transpl Immunol 7:127-128, 1999
11. Perrey C, Pravica V, Sinnott PJ, Hutchinson IV: Genotyping for polymorphisms in interferon-γ interleukin-10, transforming growth factor-β1 and tumour necrosis factor-α genes: A technical report. Transplant Immunol 6:193-197, 1998
12. Girndt M, Sester U, Sester M, et al: The interleukin-10 promotor genotype determines clinical immune function in hemodialysis patients. Kidney Int 60:2385-2391, 2001
13. Jungers P, Kiaoa TN, Massy ZA: Incidence of atherosclerotic arterial occlusive accidents in predialysis and dialysis patients: A multicentric study in the Ile de France district. Nephrol Dial Transplant 14:898-902, 1999
14. Bologa RM, Levine DM, Parker TS, et al: Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients. Am J Kidney Dis 32:107-114, 1998
15. Stenvinkel P, Heimbürger O, Paultre F, et al: Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 55:1899-1911, 1999
16. Descamps-Latscha B, Herbelin A, Nguyen AT, et al: Balance between IL-1 beta, TNF-alpha, and their specific inhibitors in chronic renal failure and maintenance dialysis. Relationships with activation markers of T cells, B cells, and monocytes. J Immunol 154:882-892, 1995
17. Girndt M, Köhler H, Schiedhelm Weick E, et al: Production of interleukin-6, tumor necrosis factor alpha and interleukin-10 in vitro correlates with the clinical immune defect in chronic hemodialysis patients. Kidney Int 47:559-565, 1995
18. Raisanen-Sokolowski A, Glysing-Jensen T, Russell ME: Leukocyte-suppressing influences of interleukin (IL)-10 in cardiac allografts: Insights from IL-10 knockout mice. Am J Pathol 153:14911500, 1998
19. Mallat Z, Heymes C, Ohan J, et al: Expression of interleukin-10 in advanced human atherosclerotic plaques: Relation to inducible nitric oxide synthase expression and cell death. Arterioscler Thromb Vasc Biol 19:611-616, 1999
20. Smith DA, Irving SD, Sheldon J, et al: Serum levels of the antiinflammatory cytokine interleukin-10 are decreased in patients with unstable angina. Circulation 104:746-749, 2001
21. Donger C, Georges JL, Nicaud V, et al: New polymorphisms in the interleukin-10 gene-relationships to myocardial infarction. Eur J Clin Invest 31:9-14, 2001